Patterns of lung function abnormalities in smokers as possible manifestation of "early" COPD phenotypes
A. Corsico, L. Carrozzi, F. Pistelli, E. Gini, F. Albicini, A. Grosso, F. Aquilini, R. Niniano, F. Imberti, E. Tsana Tegomo, M. Agnesi, A. Foresi, I. Cerveri (Pisa, Sesto San Giovanni, Italy)
Source: Annual Congress 2012 - New issues in pulmonary function
Session: New issues in pulmonary function
Session type: Thematic Poster Session
Number: 859
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Corsico, L. Carrozzi, F. Pistelli, E. Gini, F. Albicini, A. Grosso, F. Aquilini, R. Niniano, F. Imberti, E. Tsana Tegomo, M. Agnesi, A. Foresi, I. Cerveri (Pisa, Sesto San Giovanni, Italy). Patterns of lung function abnormalities in smokers as possible manifestation of "early" COPD phenotypes. Eur Respir J 2012; 40: Suppl. 56, 859
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Effectiveness of a panel of sputum markers in smokers with and without COPD to detect pulmonary progression towards functional impairment Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020
Genetic features of decrease in lung function in various forms of a chronic bronchitis Source: Eur Respir J 2005; 26: Suppl. 49, 518s Year: 2005
Prevalence of lung function abnormalities in smokers with ischemic heart disease Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019
Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
Morphological markers of resistance bronchial mucosa of smokers to the development of COPD Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
Predictors of lung function deterioration in COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014
Effect of smoking on lung functions in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 157s Year: 2005
Lung function decline in relation to alpha-1-antitrypsin phenotypes in severe asthma Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003
The relationship of exacerbations and lung function decline to radiologic characteristics in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 512s Year: 2005
Who are they? Characteristics of smokers with previously undetected COPD Source: Annual Congress 2006 - COPD – the challenges for primary care Year: 2006
Impairment of lung function in asymptomatic smokers Source: Eur Respir J 2005; 26: Suppl. 49, 152s Year: 2005
Prenosological diagnosis of respiratory function abnormalities in smokers Source: Annual Congress 2012 - Tobacco comorbidity Year: 2012
The "rapid decliner" as a COPD phenotype associated with predominant emphysema Source: Annual Congress 2011 - COPD diagnosis Year: 2011
Features of the bronchial mucosa in heavy smokers with and without chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015
Relationship between lung function disorders and condition of cardiovascular system in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 422s Year: 2003
Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008
The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories Source: Eur Respir J, 58 (5) 2004656; 10.1183/13993003.04656-2020 Year: 2021
Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT® Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012
Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015